Enzymotec Sets New 52-Week Low at $8.52 (ENZY)
Enzymotec (NASDAQ:ENZY) shares hit a new 52-week low during mid-day trading on Tuesday , AnalystRatings.NET reports. The stock traded as low as $8.52 and last traded at $8.57, with a volume of 49,934 shares. The stock had previously closed at $8.76.
ENZY has been the subject of a number of recent research reports. Analysts at Jefferies Group cut their price target on shares of Enzymotec from $14.50 to $10.00 in a research note on Wednesday, August 6th. Analysts at Wells Fargo & Co. downgraded shares of Enzymotec from an “outperform” rating to a “market perform” rating in a research note on Wednesday, August 6th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and one has assigned a buy rating to the company. Enzymotec has a consensus rating of “Hold” and an average target price of $20.00.
The stock has a 50-day moving average of $11.75 and a 200-day moving average of $17.69. The company has a market cap of $187.9 million and a price-to-earnings ratio of 25.84.
Enzymotec (NASDAQ:ENZY) last posted its quarterly earnings results on Tuesday, August 5th. The company reported $0.02 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.10 by $0.08. The company had revenue of $11.50 million for the quarter, compared to the consensus estimate of $14.88 million. The company’s quarterly revenue was down 40.3% on a year-over-year basis. Analysts expect that Enzymotec will post $0.37 EPS for the current fiscal year.
Enzymotec Ltd. is engaged in manufacturing of ingredients and medical foods company. Its technologies, research, and clinical validation process enables the Company to develop differentiated solutions across a variety of products.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.